Skip to main content

Quartette FDA Approval History

FDA Approved: Yes (First approved March 28, 2013)
Brand name: Quartette
Generic name: levonorgestrel/ethinyl estradiol and ethinyl estradiol
Dosage form: Tablets
Company: Teva Branded Pharmaceutical Products R&D, Inc.
Treatment for: Birth Control

Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) is a 91-day extended regimen oral contraceptive indicated for the prevention of pregnancy.

Development timeline for Quartette

Mar 29, 2013Approval FDA Approves Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.